Literature DB >> 21943976

Experimental models for the development of new medical treatments in prostate cancer.

Anne Chauchereau1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21943976     DOI： 10.1016/S0959-8049(11)70166-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  2 in total

1.  The IGR-CaP1 xenograft model recapitulates mixed osteolytic/blastic bone lesions observed in metastatic prostate cancer.

Authors:  Nader Al Nakouzi; Olivia Bawa; Alain Le Pape; Stéphanie Lerondel; Catherine Gaudin; Paule Opolon; Patrick Gonin; Karim Fizazi; Anne Chauchereau
Journal:  Neoplasia       Date:  2012-05       Impact factor: 5.715

2.  Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer.

Authors:  Lucas Daniel Gentilini; Felipe Martín Jaworski; Carolina Tiraboschi; Ignacio González Pérez; Monica Lidia Kotler; Anne Chauchereau; Diego Jose Laderach; Daniel Compagno
Journal:  Oncotarget       Date:  2017-07-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.